Mutual of America Capital Management LLC boosted its position in The Clorox Company (NYSE:CLX – Get Rating) by 2.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,858 shares of the company’s stock after buying an additional 359 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Clorox were worth $2,377,000 at the end of the most recent quarter.
A number of other institutional investors have also recently added to or reduced their stakes in CLX. Park Avenue Securities LLC acquired a new position in Clorox in the 1st quarter worth $242,000. FDx Advisors Inc. raised its stake in shares of Clorox by 15.1% in the 1st quarter. FDx Advisors Inc. now owns 1,740 shares of the company’s stock valued at $242,000 after purchasing an additional 228 shares in the last quarter. State of New Jersey Common Pension Fund D raised its stake in shares of Clorox by 5.6% in the 1st quarter. State of New Jersey Common Pension Fund D now owns 71,301 shares of the company’s stock valued at $9,913,000 after purchasing an additional 3,781 shares in the last quarter. Metis Global Partners LLC acquired a new stake in shares of Clorox in the 1st quarter valued at about $270,000. Finally, Mount Yale Investment Advisors LLC raised its stake in shares of Clorox by 5.1% in the 1st quarter. Mount Yale Investment Advisors LLC now owns 2,574 shares of the company’s stock valued at $358,000 after purchasing an additional 124 shares in the last quarter. Institutional investors and hedge funds own 81.69% of the company’s stock.
Clorox Price Performance
NYSE CLX opened at $151.00 on Wednesday. The Clorox Company has a 52 week low of $120.50 and a 52 week high of $186.86. The company has a current ratio of 0.88, a quick ratio of 0.50 and a debt-to-equity ratio of 4.99. The stock has a market cap of $18.63 billion, a price-to-earnings ratio of 46.32, a price-to-earnings-growth ratio of 3.06 and a beta of 0.31. The company has a 50-day moving average price of $138.65 and a two-hundred day moving average price of $141.61.
Clorox Announces Dividend
Wall Street Analyst Weigh In
A number of equities research analysts have recently issued reports on CLX shares. Barclays upped their target price on shares of Clorox from $93.00 to $101.00 and gave the company an “underweight” rating in a research note on Friday, August 19th. UBS Group upped their target price on shares of Clorox from $119.00 to $129.00 and gave the company a “sell” rating in a research note on Wednesday, November 2nd. Wells Fargo & Company lowered their price objective on shares of Clorox from $130.00 to $125.00 and set an “underweight” rating for the company in a research report on Monday, October 3rd. Morgan Stanley boosted their price objective on shares of Clorox from $130.00 to $142.00 and gave the company an “equal weight” rating in a research report on Wednesday, November 2nd. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Clorox from $138.00 to $148.00 and gave the company a “hold” rating in a research report on Wednesday, November 2nd. Ten equities research analysts have rated the stock with a sell rating, four have issued a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Reduce” and an average target price of $135.08.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
- Get a free copy of the StockNews.com research report on Clorox (CLX)
- After Nixing its 13% Dividend, Is Lumen Technologies Okay To Own?
- Cisco Systems Hopes Restructuring Cuts Costs to Drive Revenue
- The Sell-Side Caps Gains In Dick’s Sporting Goods
- Stock-ing Stuffers: 3 Attractive Stocks Trading Around $10
- Want to Get a 10% Dividend Yield, Look Here
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.